Fisher B - Search Results

1

A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers.

MacKenzie MJ, Hirte HW, Siu LL, Gelmon K, Ptaszynski M, Fisher B, Eisenhauer E. MacKenzie MJ, et al. Among authors: fisher b. Ann Oncol. 2004 Apr;15(4):665-70. doi: 10.1093/annonc/mdh133. Ann Oncol. 2004. PMID: 15033677 Free article. Clinical Trial.

2

Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group.

Rusthoven JJ, Eisenhauer E, Butts C, Gregg R, Dancey J, Fisher B, Iglesias J. Rusthoven JJ, et al. Among authors: fisher b. J Clin Oncol. 1999 Apr;17(4):1194. doi: 10.1200/JCO.1999.17.4.1194. J Clin Oncol. 1999. PMID: 10561178 Clinical Trial.

3

Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study.

Cripps C, Burnell M, Jolivet J, Batist G, Lofters W, Dancey J, Iglesias J, Fisher B, Eisenhauer EA. Cripps C, et al. Among authors: fisher b. Ann Oncol. 1999 Oct;10(10):1175-9. doi: 10.1023/a:1008372529239. Ann Oncol. 1999. PMID: 10586333 Free article. Clinical Trial.

4

Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.

Gelmon KA, Latreille J, Tolcher A, Génier L, Fisher B, Forand D, D'Aloisio S, Vernillet L, Daigneault L, Lebecq A, Besenval M, Eisenhauer E. Gelmon KA, et al. Among authors: fisher b. J Clin Oncol. 2000 Dec 15;18(24):4098-108. doi: 10.1200/JCO.2000.18.24.4098. J Clin Oncol. 2000. PMID: 11118471 Clinical Trial.

5

A phase 1 study of OSI-211 given as an intravenous infusion days 1, 2, and 3 every three weeks in patients with solid cancers.

Gelmon K, Hirte H, Fisher B, Walsh W, Ptaszynski M, Hamilton M, Onetto N, Eisenhauer E. Gelmon K, et al. Among authors: fisher b. Invest New Drugs. 2004 Aug;22(3):263-75. doi: 10.1023/B:DRUG.0000026252.86842.e2. Invest New Drugs. 2004. PMID: 15122073 Clinical Trial.

6

A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149).

Hirte H, Oza A, Swenerton K, Ellard SL, Grimshaw R, Fisher B, Tsao M, Seymour L. Hirte H, et al. Among authors: fisher b. Gynecol Oncol. 2010 Sep;118(3):308-12. doi: 10.1016/j.ygyno.2010.05.005. Epub 2010 Jun 19. Gynecol Oncol. 2010. PMID: 20646751 Clinical Trial.

7

Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer.

Gelmon K, Eisenhauer E, Bryce C, Tolcher A, Mayer L, Tomlinson E, Zee B, Blackstein M, Tomiak E, Yau J, Batist G, Fisher B, Iglesias J. Gelmon K, et al. Among authors: fisher b. J Clin Oncol. 1999 Oct;17(10):3038-47. doi: 10.1200/JCO.1999.17.10.3038. J Clin Oncol. 1999. PMID: 10506598 Clinical Trial.

8

Phase I study of paclitaxel (Taxol) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.

Shepherd FA, Latreille J, Crump M, Stewart D, Tomiak E, Eisenhauer E, Fisher B. Shepherd FA, et al. Among authors: fisher b. Ann Oncol. 1996 Mar;7(3):311-3. doi: 10.1093/oxfordjournals.annonc.a010577. Ann Oncol. 1996. PMID: 8740797 Free article. Clinical Trial.

9

A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.

Swenerton K, Hoskins P, Stuart G, Batist G, Pike J, Onetto N, Fisher B, Eisenhauer E. Swenerton K, et al. Among authors: fisher b. Ann Oncol. 1996 Dec;7(10):1077-9. doi: 10.1093/oxfordjournals.annonc.a010502. Ann Oncol. 1996. PMID: 9037368 Free article. Clinical Trial.

10

Phase II trial of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine.HCl and doxorubicin chemotherapy in metastatic breast cancer: A National Cancer Institute of Canada clinical trials group study.

Khoo K, Brandes L, Reyno L, Arnold A, Dent S, Vandenberg T, Lebwohl D, Fisher B, Eisenhauer E. Khoo K, et al. Among authors: fisher b. J Clin Oncol. 1999 Nov;17(11):3431-7. doi: 10.1200/JCO.1999.17.11.3431. J Clin Oncol. 1999. PMID: 10550138 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,068 results

Search Page

Filters